A study featuring the participation of Fisabio (Foundation for the Promotion of Health and Biomedical Research of Valencia Region), dependent on the Conselleria de Sanitat Universal i Salut Pública, has found that the predominant lineage in Europe of gonococcus the bacterium which causes gonorrhea is resistant to one of the two drugs, among others, most commonly used today to treat this disease.